211 related articles for article (PubMed ID: 35412062)
1. Dexmedetomidine attenuates hippocampal neuroinflammation in postoperative neurocognitive disorders by inhibiting microRNA-329-3p and activating the CREB1/IL1RA axis.
Chen J; Ding Q; Jiao X; Wang B; Sun Z; Zhang Y; Zhao J
Psychopharmacology (Berl); 2022 Jul; 239(7):2171-2186. PubMed ID: 35412062
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-181b-5p attenuates early postoperative cognitive dysfunction by suppressing hippocampal neuroinflammation in mice.
Lu Y; Xu X; Dong R; Sun L; Chen L; Zhang Z; Peng M
Cytokine; 2019 Aug; 120():41-53. PubMed ID: 31003188
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine attenuates neuroinflammation and microglia activation in LPS-stimulated BV2 microglia cells through targeting circ-Shank3/miR-140-3p/TLR4 axis.
He G; He Y; Ni H; Wang K; Zhu Y; Bao Y
Eur J Histochem; 2023 Jul; 67(3):. PubMed ID: 37491974
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine mitigates neuroinflammation and improves early postoperative neurocognitive dysfunction in rats by enhancing autophagy.
Wang J; Xin Y; Chu T; Zhou Y; Liu C; Xu A
J Neurophysiol; 2023 May; 129(5):1145-1156. PubMed ID: 37042554
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine Ameliorates Postoperative Cognitive Dysfunction via the MicroRNA-381-Mediated EGR1/p53 Axis.
Wang YL; Zhang Y; Cai DS
Mol Neurobiol; 2021 Oct; 58(10):5052-5066. PubMed ID: 34245441
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA cerebellar degeneration-related protein 1 antisense RNA (Circ-CDR1as) downregulation induced by dexmedetomidine treatment protects hippocampal neurons against hypoxia/reoxygenation injury through the microRNA-28-3p (miR-28-3p)/tumor necrosis factor receptor-associated factor-3 (TRAF3) axis.
Wang J; Wang Y
Bioengineered; 2021 Dec; 12(2):10512-10524. PubMed ID: 34787053
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-146a protects against cognitive decline induced by surgical trauma by suppressing hippocampal neuroinflammation in mice.
Chen L; Dong R; Lu Y; Zhou Y; Li K; Zhang Z; Peng M
Brain Behav Immun; 2019 May; 78():188-201. PubMed ID: 30685530
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine mitigates neuroinflammation in an Alzheimer's disease mouse model via the miR-204-3p/FBXL7 signaling axis.
Lian X; Zhang X; Chen W; Xue F; Wang G
Brain Res; 2024 Jan; 1822():148612. PubMed ID: 37778649
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine Attenuates Neuroinflammation In LPS-Stimulated BV2 Microglia Cells Through Upregulation Of miR-340.
Bao Y; Zhu Y; He G; Ni H; Liu C; Ma L; Zhang L; Shi D
Drug Des Devel Ther; 2019; 13():3465-3475. PubMed ID: 31631971
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine attenuates the neuroinflammation and cognitive dysfunction in aged mice by targeting the SNHG14/miR‑340/NF‑κB axis.
He G; Ni H; Wang K; Gao H; Li Y; Gu J; Ni X; Wang Z; Bao Y
Biomed Rep; 2023 Dec; 19(6):100. PubMed ID: 37954634
[TBL] [Abstract][Full Text] [Related]
11. Effects of dexmedetomidine on cognitive dysfunction and neuroinflammation via the HDAC2/HIF-1α/PFKFB3 axis in a murine model of postoperative cognitive dysfunction.
Liu YF; Hu R; Zhang LF; Fan Y; Xiao JF; Liao XZ
J Biochem Mol Toxicol; 2022 Jun; 36(6):e23044. PubMed ID: 35499365
[TBL] [Abstract][Full Text] [Related]
12. The Pathway of Let-7a-1/2-3p and HMGB1 Mediated Dexmedetomidine Inhibiting Microglia Activation in Spinal Cord Ischemia-Reperfusion Injury Mice.
Ha Sen Ta Na ; Nuo M; Meng QT; Xia ZY
J Mol Neurosci; 2019 Sep; 69(1):106-114. PubMed ID: 31190218
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine Mitigates Microglial Activation Associated with Postoperative Cognitive Dysfunction by Modulating the MicroRNA-103a-3p/VAMP1 Axis.
Wu Z; Wang H; Shi Z; Li Y
Neural Plast; 2022; 2022():1353778. PubMed ID: 35494481
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine ameliorates postoperative cognitive dysfunction by inhibiting Toll-like receptor 4 signaling in aged mice.
Zhou XY; Liu J; Xu ZP; Fu Q; Wang PQ; Wang JH; Zhang H
Kaohsiung J Med Sci; 2020 Sep; 36(9):721-731. PubMed ID: 32627922
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine attenuates perioperative neurocognitive disorders by suppressing hippocampal neuroinflammation and HMGB1/RAGE/NF-κB signaling pathway.
Wang J; Xin Y; Chu T; Liu C; Xu A
Biomed Pharmacother; 2022 Jun; 150():113006. PubMed ID: 35486975
[TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine Ameliorates Postoperative Cognitive Dysfunction in Aged Mice.
Xie X; Shen Z; Hu C; Zhang K; Guo M; Wang F; Qin K
Neurochem Res; 2021 Sep; 46(9):2415-2426. PubMed ID: 34159456
[TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine suppresses hippocampal astrocyte pyroptosis in cerebral hypoxic-ischemic neonatal rats by upregulating microRNA-148a-3p to inactivate the STAT/JMJD3 axis.
Zhong Y; Wang S; Yin Y; Yu J; Liu Y; Gao H
Int Immunopharmacol; 2023 Aug; 121():110440. PubMed ID: 37327511
[TBL] [Abstract][Full Text] [Related]
18. A Causal Relationship in Spinal Cord Injury Rat Model Between Microglia Activation and EGFR/MAPK Detected by Overexpression of MicroRNA-325-3p.
Yan P; Wu X; Liu X; Cai Y; Shao C; Zhu G
J Mol Neurosci; 2019 Jun; 68(2):181-190. PubMed ID: 30911940
[TBL] [Abstract][Full Text] [Related]
19. Activating astrocytic α2A adrenoceptors in hippocampus reduces glutamate toxicity to attenuate sepsis-associated encephalopathy in mice.
Mei B; Xu X; Weng J; Yang Y; Wang P; Qiu G; Zhang C; Zhang Q; Lu Y; Liu X
Brain Behav Immun; 2024 Mar; 117():376-398. PubMed ID: 38320682
[TBL] [Abstract][Full Text] [Related]
20. LncRNA H19 Regulates Lipopolysaccharide (LPS)-Induced Apoptosis and Inflammation of BV2 Microglia Cells Through Targeting miR-325-3p/NEUROD4 Axis.
Gu E; Pan W; Chen K; Zheng Z; Chen G; Cai P
J Mol Neurosci; 2021 Jun; 71(6):1256-1265. PubMed ID: 33205379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
